Working… Menu

Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA) (OPTIRPE65)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02781480
Recruitment Status : Completed
First Posted : May 24, 2016
Last Update Posted : July 17, 2019
Information provided by (Responsible Party):
MeiraGTx UK II Ltd

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2018
Actual Study Completion Date : December 2018